Ananda Impact Ventures is an impact-focused venture capital fund with a pan-European investment remit, managing €150m across four Core Impact Funds.
Portfolio
4
companies
Closed Loop Medicine
Closed Loop Medicine develops integrated drug and digital therapeutics to enable precision dosing.
DrDoctor
DrDoctor provides digital care solutions to connect patients and clinicians across the health service.
Ieso Digital Health
Digital mental healthcare provider developing AI enabled therapeutics.
Oneday
Oneday provides an entrepreneurship-focused education platform and accredited MBA degree.
Zoe Peden
Partner
Zoe brings venture capital experience as a partner at Ananda Impact Ventures and founder of FutureWorldVC. She also serves as chair of the investment committee at Young Lives Innovation Lab.
LinkedInLennart Hergel
The funding round was backed by investors including Ananda Impact Ventures and Brighteye Ventures to support the launch of a new entrepreneurial MBA.
"Following a successful fundraise of £8.25 million, we are hugely excited to launch our new MBA programme, which is just the first step in creating a broader education system around entrepreneurship."
YFM Equity Partners led a £10m investment into healthtech company DrDoctor to scale its patient engagement platform.
"If personalised care is to become an NHS-wide reality, there needs to be a fundamental shift in the way we approach healthcare. We see this latest support from our investors as confirmation of our role as a key enabler for these necessary changes. We’ve already proven how a digital-first approach can have a profound effect on productivity, evidenced by our substantial footprint in the NHS. Thanks to this latest investment, we are moving forward with some incredibly exciting projects, accelerating our journey to delivering truly modern healthcare."
Morningside led the Series B financing to support regulatory approvals and market entry for clinical software treatments.
"At ieso, we’re looking to transform global mental health by unlocking the power of clinical data to develop AI-enabled digital therapeutics. Our experience delivering outstanding mental health care within the NHS ideally places us for starting to tackle this challenge. A new generation of clinically-validated digital mental health care products could ultimately improve millions of lives. But we cannot do this alone, and look forward to working with our patients, clinicians, investors, as well as existing and future partners, to better serve those who require mental health support."
The financing round was co-led by Ananda Impact Ventures and BGF to accelerate platform and product development.
Ananda Impact Ventures and 24Haymarket led the Series A round to support product expansion and team growth.
"The team at DrDoctor have never been busier as we work to help our NHS Trusts break the backlog in care that has been created by the havoc of Covid-19. Having the backing of Ananda Impact Ventures and 24Haymarket will help us meet the tremendous demand that now exists for our services as care and patient communication goes digital. We are delighted to have their support."
